Skip to main content

Table 1 Clinical and pathological characteristics

From: Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study

Number 88
Age (years)a 62 (57–70)
Sex Male: Female 71:17
Advanced liver disease 18 (20.5)
Pulmonary disease 17 (19.3)
Tumor location:
 Upper thoracic esophagus 14 (15.9)
 Middle thoracic esophagus 38 (43.2)
 Lower thoracic esophagus 36 (40.9)
Tumor differentiation:
 Well 16 (18.2)
 Moderately 57 (64.8)
 Poor 15 (17.0)
Tumor length (mm)a 50 (40–70)
Pathologic T stage
 T1 11 (12.5)
 T2 10 (11.4)
 T3 58 (65.9)
 T4 9 (10.2)
Harvested lymph nodesa 17 (12–25)
Lymph node metastasis:
 Peritumoral or Peritumoral and distant (non-NSM) 72 (81.8)
 Only distant (NSM) 16 (18.2)
Adjuvant therapy: yes 28 (31.8)
  1. Data expressed as n (%) or amedian(IQR). NSM: nodal skip metastasis